Tenax Days Sales Outstanding from 2010 to 2025

TENX Stock  USD 5.97  0.04  0.67%   
Tenax Therapeutics Days Sales Outstanding yearly trend continues to be fairly stable with very little volatility. Days Sales Outstanding will likely drop to 166.06 in 2025. During the period from 2010 to 2025, Tenax Therapeutics Days Sales Outstanding regression line of annual values had r-squared of  0.08 and arithmetic mean of  294.49. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
329.58
Current Value
166.06
Quarterly Volatility
130.3504728
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tenax Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tenax Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.3 K, Other Operating Expenses of 8.4 M or Research Development of 3.6 M, as well as many indicators such as Price To Sales Ratio of 141.3 K, Dividend Yield of 3.31 or PTB Ratio of 0.64. Tenax financial statements analysis is a perfect complement when working with Tenax Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Tenax Therapeutics Correlation against competitors.
For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.

Latest Tenax Therapeutics' Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Tenax Therapeutics over the last few years. It is Tenax Therapeutics' Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tenax Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

Tenax Days Sales Outstanding Regression Statistics

Arithmetic Mean294.49
Geometric Mean241.11
Coefficient Of Variation44.26
Mean Deviation107.78
Median366.20
Standard Deviation130.35
Sample Variance16,991
Range457
R-Value0.28
Mean Square Error16,762
R-Squared0.08
Significance0.29
Slope7.71
Total Sum of Squares254,869

Tenax Days Sales Outstanding History

2025 166.06
2024 329.58
2015 366.2
2013 96.68
2012 19.55
2011 476.19
2010 231.25

About Tenax Therapeutics Financial Statements

Tenax Therapeutics investors use historical fundamental indicators, such as Tenax Therapeutics' Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tenax Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Sales Outstanding 329.58  166.06 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tenax Stock Analysis

When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.